CorMedix (CRMD) Stock: Buy, Sell, or Hold?
$5.30
-0.07 (-1.30%)
▼
5d:
-6.36%
30d:
-28.28%
90d:
-34.89%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
0d
Protect CRMD Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$5.86 – $7.92
Position: OVERSOLD
Forward P/E & Valuation
-240.9x
CHEAP
vs 59.9x historical avg
Wall Street Target
$15.40
+190.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.10 / $8.35
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: CRMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When CRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRMD is currently trading at $5.30, which is considered oversold relative to its 30-day fair value range of $5.86 to $7.92. From a valuation perspective, the stock is trading at a discount (Forward PE: -240.9) compared to its historical average (59.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CRMD is in a downtrend. Immediate support is located at $5.10, while resistance sits at $8.35.
Market Sentiment: CRMD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.40 (+190.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRMD is in a downtrend. Immediate support is located at $5.10, while resistance sits at $8.35.
Market Sentiment: CRMD scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.40 (+190.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.86 -
$7.92
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Trading Range & Key Levels
30-Day Trading Range
$5.86 -
$7.92
Current vs Trading Range
OVERSOLD
Support Level
$5.10
Resistance Level
$8.35
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding CRMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 190.6% below Wall St target ($15.40)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 18% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-240.91
Wall Street Target
$15.40
(+190.6%)
Revenue Growth (YoY)
156.5%
Earnings Growth (YoY)
6.7%
Profit Margin
40.5%
PE vs Historical
-240.9 vs 59.9
CHEAP
Share CRMD Analysis
Share this live CRMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRMD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism about $CRMD's European market re-entry plans with several pipeline drugs, including Defencath and Heron Deal. The trader also mentions the anticipation of EP450774 closing.
Key Retail Themes:
European market re-entry
Pipeline drugs
Heron Deal
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:30 AM ET
Data refreshes hourly during market hours. Next update: 9:30 AM
Data refreshes hourly during market hours. Next update: 9:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 44 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 55 HOLD |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 35 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$75 | 66 BUY |
Advanced CRMD Option Strategies
Professional options setups generated by AI based on today's CRMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRMD Research Pages
